EWA
CRVO icon

EverSource Wealth Advisors’s CervoMed CRVO Stock Holding History

EverSource Wealth Advisors’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-36
Closed -$226 – 4353
2025
Q2 		$226 Hold
36
– – ﹤0.01% 4041
2025
Q1 		$329 Buy
+36
New +$137 ﹤0.01% 3580

Other funds holding CRVO

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

EverSource Wealth Advisors's CRVO Position: Q3 2025 in Review

EverSource Wealth Advisors sold out of CervoMed (CRVO) in Q3 2025, closing a stake of 36 shares — an estimated $226 sold.

EverSource Wealth Advisors first reported a position in CRVO in Q1 2025 and held it in 2 quarters. The position peaked at $329 in Q1 2025. 45 funds tracked by Wall St. Rank hold CRVO as of Q3 2025.

  • EverSource Wealth Advisors reported no remaining CervoMed position as of Q3 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 36 CervoMed shares in Q3 2025, an estimated $226.
  • EverSource Wealth Advisors first reported a position in CervoMed in Q1 2025 and held it in 2 quarters.
  • EverSource Wealth Advisors's CervoMed position peaked at $329 in Q1 2025.
  • 45 funds tracked by Wall St. Rank held CervoMed as of Q3 2025.

Based on EverSource Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.